Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
29 Cards in this Set
- Front
- Back
What cancer type do fibroids fall under?
|
Leiomyoma
|
|
What is tumor heterogeneity?
|
Refers to tumor undergoing additional mutations with each doubling and the subsequent gain of add'l abilities
|
|
Role of telomerase in cancer cells.
|
Limitless replication potential
Telomerase activation voids telomere time clock |
|
Under what conditions are angiogenic factors produced? Ex. of angiogenic factor?
|
Hypoxia; VEGF
|
|
How do proteases from tumor/stroma mediate anti-angiogenic effects?
|
Cleavage of plasminogen to angioSTATIN (anything -statin means STOPPING)
|
|
Role of HIF-1alpha
Mechanism? |
Angiogenic switch:
HIF-1alpha binds VHL in presence of O2, and gets degraded In absence of O2, binds nuc and upregs VEGF |
|
How do cells loosen from each other during cancer invasion? How do they enter the ECM?
|
Downregulation of cadherins (intercell jn)
First have to adhere to ECM via expression of LAMININ receptors, then degrade matrix via Type IV COLLAGENASE and PLASMINOGEN ACTIVATORS |
|
How does spread of carcinomas differ from spread of sarcomas?
|
Carcinomas likely to spread to sentinel LN
Sarcomas likely to spread to blood flow |
|
Two examples of growth stimulatory factors.
One example of growth inhibitory factor. One example of cell adhesion molecule. What do they have in common? |
PDGF, FGF: Growth stimulatory
TGF-beta: Growth inhibitory factor Cell adhesion: Cadherins---Catenins All result in intracellular PW with RAS (G-prot; and tyrosine kinase) |
|
Effect of stimulatory factors on CDK?
|
GF's upregulate CDK's
|
|
Role of BCL-2
|
Apoptotic INHIBITOR
|
|
Effect of inhibitory factors on Rb
|
IF's activate Rb (and CDK-I's)
|
|
How do CDK's and CDK-I's interact with Rb?
|
CDK Pi's Rb, releases EGF, allows progression into S phase
CDK-I's de-pi (?) |
|
2 examples of CDK-I's. Role?
|
p21 (produced by p53) - inhibits progression to G1, G2
p16 - inhibits progression to G1 |
|
When is RAS activated? What happens it it's mutated at site of GTP hydrolysis?
|
RAS activated by binding of GF to GF-r
If mutated at site of GTP hydrolysis, won't shut itself off and continuously drives cell proliferation |
|
What would a blood smear show in chronic myelogenous leukemia? Hallmark?
|
would demonstrate leukocytosis: mature neutrophils/immature myelocytes (young granulocyte)
Hallmark: balanced chrom translocn between 9 and 22 |
|
What is the effect of a balanced chromosomal translocation in CML?
|
Get a hybrid gene that acts as a non-localized tyrosine kinase; it's in cytoplasm and cells no longer require GF's
Unaffected by inhibitory factors, evade apoptosis |
|
Genetic mechanism behind neuroblastoma.
|
Amplification of N-myc gene (cell cycle stimulatory gene)
|
|
Why is HER2/NEU an oncogene?
|
It's a growth factor receptor; it's over-expression leads to cancer
|
|
What is the Kanutzen hypothesis re: retinoblastoma?
|
Rb can be hereditary (inherit first hit, develop 2nd hit) or sporadic (develop both hits via mutations in retinoblasts)
|
|
Example of AD cancer syndrome. Associated symptom?
|
Retinoblastoms is AD
AD Cancer syndromes often involve multiple (benign) cancers at many sites |
|
Role of Rb?
|
Impt in G1 checkpoint; normally bound to E2F, when CDK Pi's, E2F released and binds transcription factor, allowing progression to S phase
|
|
What is p16? AKA?
|
CDK-I
p16 = INK4a |
|
What is epigenetic silencing and how does it occur?
|
Silencing of a gene via methylation at promoter region, prevents transcription factor binding
|
|
Via what agent does p53 mediate cell cycle arrest? Apoptosis?
|
p21
Mediates apoptosis via increase in BAX |
|
What disease are APC mutations associated with?
|
Colon cancer; APC acts as tumor suppressor
|
|
What is hereditary adenomatous polyposis syndrome? Cause?
|
1000's of polyps developed at young age due to mutation of APC
|
|
Mechanism of APC.
|
APC binds beta-catenin in cytoplasm
when WNT binds extracell WNT-R, beta-catenin released and acts as transcription factor (increases proliferation) |
|
Effect of knocking out APC.
|
beta-catenin unbound and upregulated proliferation
|